Human Molecular Genetics Advance Access published online on December 8, 2003
Human Molecular Genetics, doi:10.1093/hmg/ddh026
© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD
* To whom correspondence should be addressed. E-mail: kraemerk{at}nih.gov.
The lariat branch point sequence (BPS) is crucial for splicing of human nuclear pre-mRNA yet BPS mutations have infrequently been reported to cause human disease. Using an inverse RT-PCR technique we mapped two BPS's to the adenosine residues at positions -4 and -24 in intron 3 of the human XPC DNA repair gene. We identified homozygous mutations in each of these BPS in two newly diagnosed Turkish families with the autosomal recessive disorder xeroderma pigmentosum (XP). Cells from two severely affected children in family A harbor a homozygous point mutation in XPC intron 3 (-9 T to A), located within the downstream BPS. Using a real-time quantitative reverse transcriptase - polymerase chain reaction (QRT-PCR) assay, these cells expressed no detectable (<0.1%) normal XPC message. Instead they expressed an XPC mRNA isoform with deletion of exon 4 that has no DNA repair activity in a host cell reactivation (HCR) assay. In contrast, in cells from three mildly affected siblings in family B the BPS adenosine located at the -24 position in XPC intron 3 is mutated to a G. Real-time QRT-PCR revealed 3-5% of normal XPC message. These cells from family B had a higher level of HCR than cells from the severely affected siblings in family A who had multiple skin cancers. Mutations identified in two BPS of the XPC intron 3 resulted in alternative splicing that impaired DNA repair function, thus implicating both of these BPS as essential for normal pre-mRNA splicing. However, a small amount of normal XPC mRNA can provide partial protection against skin cancers.
Article
Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: Mutations result in reduced XPC mRNA levels that correlate with cancer risk
2 Department of Dermatology, Yüzuüncuü Yil University Medical School, Van, Turkey
3 Department of Biochemistry, Inoünuü University Medical School, Malatya, Turkey
4 Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
5 Laboratory of Experimental and Computational Biology, National Cancer Institute, Frederick, MD
6 DNA Repair Section, Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Building 37 Room 4002 MSC 4258, Bethesda, MD 20892-4258
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F.-O. Desmet, D. Hamroun, M. Lalande, G. Collod-Beroud, M. Claustres, and C. Beroud Human Splicing Finder: an online bioinformatics tool to predict splicing signals Nucleic Acids Res., May 1, 2009; 37(9): e67 - e67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gao, A. Masuda, T. Matsuura, and K. Ohno Human branch point consensus sequence is yUnAy Nucleic Acids Res., April 1, 2008; 36(7): 2257 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yasuda, R. Nishi, E. Watanabe, T. Mori, S. Iwai, D. Orioli, M. Stefanini, F. Hanaoka, and K. Sugasawa In Vivo Destabilization and Functional Defects of the Xeroderma Pigmentosum C Protein Caused by a Pathogenic Missense Mutation Mol. Cell. Biol., October 1, 2007; 27(19): 6606 - 6614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sinnreich, C. Therrien, and G. Karpati Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy Neurology, April 11, 2006; 66(7): 1114 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vivenza, L. Guazzarotti, M. Godi, D. Frasca, B. di Natale, P. Momigliano-Richiardi, G. Bona, and M. Giordano A Novel Deletion in the GH1 Gene Including the IVS3 Branch Site Responsible for Autosomal Dominant Isolated Growth Hormone Deficiency J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 980 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Khan, K.-S. Oh, T. Shahlavi, T. Ueda, D. B. Busch, H. Inui, S. Emmert, K. Imoto, V. Muniz-Medina, C. C. Baker, et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients Carcinogenesis, January 1, 2006; 27(1): 84 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Marin, M. F. Lopez-Cima, L. Garcia-Castro, T. Pascual, M. G. Marron, and A. Tardon Poly (AT) Polymorphism in Intron 11 of the XPC DNA Repair Gene Enhances the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1788 - 1793. [Abstract] [Full Text] [PDF]
|
|